Evidence-based Management of Metastatic Colorectal Cancer in the Community

This is a member only event.  

Jeffrey A. Meyerhardt, MD, MPH Associate Professor of Medicine, Dana-Farber Cancer Institute, Boston, MA  and Cathy Eng, MD, FACP Associate Professor, Associate Medical Director, Colorectal Center, Director of Network Clinical Research, GI Medical Oncology, Co-Chair SWOG Rectal Subcommittee, NCTN Institutional Grant, Lead Contact PI, The University of Texas M.D. Anderson Cancer Center will present “Evidence-based Management of Metastatic Colorectal Cancer.” 

Objectives:

At the conclusion of this activity, participants will be able to:

Apply emerging evidence supporting the role of prognostic and predictive markers for personalized treatment planning in mCRC

Incorporate updated clinical guidelines and newly approved agents into mCRC treatment planning

Integrate evidence-based data for patients with mCRC beyond progression

Assess emerging data from late-state clinical studies and identify relevant clinical trial opportunities for patients with mCRC

Please RSVP by Friday, June 6, 2014 to Megan Hayes by phone at 302-224-5181 or by email at megan.hayes@medsocdel.org.